NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 25 of 25 results found.

Activity Company Description Location
Company 3i-Nano Activity: Research and Development Research and Development Company Description 3i Nano develops point-of-care devices for disease diagnostics and protein detection. Potential applications include cardiac, sepsis, meningitis, and respiratory. Location Greensboro
Company Aceragen Inc. Activity: Research and Development Research and Development Company Description Aceragen is a clinical-stage biopharmaceutical company developing therapeutics for rare and orphan pulmonary and rheumatic diseases with high unmet medical need, including a late-stage therapy for Farber disease. Location Research Triangle Park
Company Adroit Pharmaceutical Development LLC Activity: Contract Research and Testing Contract Research and Testing Company Description Adroit Pharmaceutical Development identifies new and improved formulations and process technologies. Its primary focus is on inhalation and dermatological product development. Location Durham
Company Aer Therapeutics Activity: Research and Development Research and Development Company Description Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung diseases with excess mucus and mucus plugs. Location Raleigh
Company Altavant Sciences Inc. Activity: Research and Development Research and Development Company Description Altavant is a clinical stage biopharmaceutical company developing therapies for rare respiratory diseases. Altavant's therapeutic focus is in pulmonary arterial hypertension (PAH) and bronchiolitis obliterans syndrome (BOS). Location Cary
Company APIE Therapeutics Inc. Activity: Research and Development Research and Development Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. Location Cary
Company BioMarck Pharmaceuticals Ltd. Activity: Research and Development Research and Development Company Description BioMarck develops drugs to treat pulmonary diseases and disorders, such as chronic obstructive pulmonary disease, ARDS, cystic fibrosis and lung cancer. Location Durham
Company BioMedInnovations LLC Activity: Research and Development Research and Development Company Description BioMedInnovations (BMI) makes precision air and fluid flow devices, including products for lung ventilators and ex-vivo organ and tissue perfusion. Location Denver
Company BreStem Therapeutics Inc. Activity: Research and Development Research and Development Company Description BreStem Therapeutics is developing a stem cell therapy to treat pulmonary fibrosis. Location Raleigh
Company Columbia Life Systems Inc. Activity: Research and Development Research and Development Company Description Columbia Life Systems is developing a computer-controlled oxygen blender for therapeutic research. Location Chapel Hill
Company Concentrx Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Concentrx develops inhaled prescription products for asthma and COPD, including a unit dose disposable dry powder inhaler. Location Durham
Company Eldec Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Eldec Pharmaceuticals is developing anti-inflammatory peptides for the treatment of chronic lung disease. Location Chapel Hill
Company Inhalon Biopharma Inc. Activity: Research and Development Research and Development Company Description Inhalon Biopharma is developing monoclonal antibodies (mAb) using technology that enables trapping of pathogens in mucus secretions for treating diseases of the respiratory tract. Location Carrboro
Company Irex Pharma LLC Activity: Research and Development Research and Development Company Description Irex Pharma is an early-stage drug discovery company focused on identifying and commercializing novel therapeutics to control excess mucus in pulmonary patients. Location Chapel Hill
Company North Carolina Clinical Research Activity: Contract Research and Testing Contract Research and Testing Company Description North Carolina Clinical Research conducts phase one through four trials at its outpatient clinical research facility. Study indications include allergy (seasonal and perennial), asthma, COPD, vaccine, migraine and bioequivalent studies. Location Raleigh
Company Path BioAnalytics Inc. Activity: Research and Development Research and Development Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. Location Durham
Company Polarean Inc. Activity: Production and Manufacturing Production and Manufacturing Company Description Polarean designs and manufactures equipment for production of hyperpolarized xenon or helium gas for use in MRI. Investigational uses include identifying early diagnoses of respiratory diseases as well as monitoring progression and therapeutic response. Location Durham
Company PulmonIx LLC Activity: Contract Research and Testing Contract Research and Testing Company Description PulmonIx conducts pulmonary, asthma and critical care medicine clinical trials. PulmonIx @ LeBauer Cone Health is a national care center of the Pulmonary Fibrosis Foundation. Location Greensboro
Company Renovion Inc. Activity: Research and Development Research and Development Company Description Renovion is developing therapies for chronic inflammatory lung diseases including lung transplant, cystic fibrosis (CF), bronchiectasis and COPD. Location Chapel Hill
Company ReViral Activity: Research and Development Research and Development Company Description ReViral develops antiviral compounds that target respiratory syncytial virus (RSV). Location Durham
Company Spirovation Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description Spirovation is a specialty CRO with a focus on the development of breakthrough drugs in respiratory medicine. Spirovation is non-profit, UNC-affiliated entity. Location Chapel Hill
Company Sunday Therapeutics Inc. Activity: Research and Development Research and Development Company Description Sunday Therapeutics is developing a humanized monoclonal antibody to prevent chronic lung disease. Location Durham
Company Vast Therapeutics Activity: Research and Development Research and Development Company Description Vast Therapeutics uses a nitric oxide technology for the treatment of cystic fibrosis and other respiratory diseases. Location Durham
Company Verona Pharma Inc. Activity: Research and Development Research and Development Company Description Verona Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of respiratory diseases such as chronic obstructive pulmonary fibrosis (COPD) and cystic fibrosis (CF). Location Raleigh
Company X-in8 Biologicals Corp. Activity: Research and Development Research and Development Company Description X-in8 Biologicals develops technologies to prevent and treat ischemia reperfusion injury in the context of organ transplant, myocardial infarction and stroke. Location Chapel Hill